Neurogene's One-Time Gene Therapy NGN-401 Receives FDA Breakthrough Nod
Neurogene’s NGN-401 gene therapy just received FDA Breakthrough Therapy Designation for Rett syndrome. Early trial results show lasting improvements in skills and daily life.
NOTRELOAD AI
CoreWeave Stock Drops on Q4 EBITDA Miss, High CapEx
CoreWeave (CRWV) beats Q4 revenue at $1.57B but misses adjusted EBITDA ($898M vs $936M est) and reports $8.2B capex. Shares fall 11% after-hours as debt climbs to $30B.
Warner Bros. board deems Paramount’s $31-per-share offer a superior deal, starting four-day countdown for Netflix response
Warner Bros. Discovery’s board just ruled Paramount Skydance’s $31-per-share bid is better than Netflix’s deal — giving Netflix only four business days to top it or step aside in this blockbuster Hollywood bidding war.
Dell Just Dropped a Monster AI Number: $50 Billion in Servers Coming in FY27
DELL reports massive Q4 and full-year 2026 results fueled by AI servers. FY2027 guidance beats Wall Street with $140B revenue expected. 20% dividend hike + $10B more buybacks.
Jack Dorsey Halves Block's Workforce in 'Intelligence-First' Overhaul
Jack Dorsey’s Block slashes workforce by nearly half (4,000 jobs) to become AI-first. Strong 2025 growth + stock jumps 24% after bold restructure.
Caesars Entertainment Eyes Buyout from Tilman Fertitta
Caesars Entertainment explores sale offers, including a bid from billionaire Tilman Fertitta. With $20B+ debt and iconic Las Vegas properties like Caesars Palace, a major casino takeover could be in play despite ongoing challenges.